MENU
TERN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Terns Pharmaceuticals (TERN) Earnings Date & Reports

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

TERN is expected to report earnings to rise 16.42% to -30 cents per share on November 18

Terns Pharmaceuticals TERN Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.04
The last earnings report on August 05 showed earnings per share of -25 cents, beating the estimate of -29 cents. With 1.18M shares outstanding, the current market capitalization sits at 492.59M.
View a ticker or compare two or three
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TERN showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1065 East Hillsdale Boulevard
Phone
+1 650 525-5535
Employees
66
Web
https://www.ternspharma.com